Zydus receives approval from COFEPRIS to market? Mamitra to treat various cancers
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
GSK and Flagship to jointly fund up to $150 million upfront
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Report highlights significant improvements in adolescent well-being in India
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
Subscribe To Our Newsletter & Stay Updated